Lifecycle Leader Cancer Immunotherapy Cross Indication

Roche fosters diversity, equity and inclusion, representing the communities we serve. When dealing with healthcare on a global scale, diversity is an essential ingredient to success. We believe that inclusion is key to understanding people’s varied healthcare needs. Together, we embrace individuality and share a passion for exceptional care. Join Roche, where every voice matters.

Global Product Strategy (GPS) drives Roche’s strategy and portfolio of products - from research through to patients. As a member of GPS, you will be part of a truly international group who collaborates with functions and affiliates worldwide to shape the future of medicine.

As Cancer Immunotherapy Cross-Indication Lifecycle Leader, you are accountable for the TECENTRIQ brand vision, strategy and key priorities, and serve as a connector and catalyst to drive realization of this ambition. You will be the Lifecycle Leader point of contact, in partnership with the Disease Area Director for the aPD1-LAG3 (Tobemstemig) program. You are responsible for identifying opportunities and driving efforts to capitalize on cross-indication synergies and for highlighting and mitigating systemic program risk. You are expected to work collaboratively with the appropriate lifecycle teams to ensure strategic alignment between disease area and molecule priorities and to actively look for synergies with those LCTs. You will align indication teams on cross-indication opportunities and risks, and provide advice to indication teams on cross-indication implications of disease-specific strategic choices. You will work closely with the TECENTRIQ Optimization Global Development Leader (GDL) and with the TECENTRIQ and tiragolumab ISLs for the global development and commercialization strategy for the portfolio assets you manage; this will be done in the context of disease level strategies where applicable. You will be accountable for seeking appropriate internal and external advice for recommendations and to ensure decisions are in line with portfolio strategies, reflecting the late stage portfolio principles of Patient, Science, Society and Value Capture.

In this position, you will be primarily accountable for consistently and effectively:

• Designing LCT composition, selection of people on the team and leading direct as well as indirect reports on the LCT

• Leading set-up of sub-team and working group composition, embracing the networked way of working, the agile principles and driving the adoption of Outcomes Based Planning

• Establishing the strategy for assigned product(s), ensuring appropriate funding, and line of sight to all relevant functions

• Ensuring timely, on target and within budget delivery against the molecule strategy, including key milestones, financial targets and other quantitative and qualitative objectives and goals

• Aligning global functions and affiliates in accordance with the molecule strategy and priorities

• Handling issue and crisis management for all activities associated with the molecule strategy

• Delivering communication of key and impactful information and issues to senior management and to all relevant stakeholders

Qualifications:

• Bachelor Degree (marketing, business management or life sciences discipline is preferred)

• MBA, Advanced Healthcare Professional (MD, PhD, NP) or other relevant Graduate or Postgraduate Degree

Experience:

• 15 or more years’ multidisciplinary experience in the pharmaceutical/biotechnology industry10 or more years’ people management experience

• 10 or more years experience in oncology therapeutic area

• Prior Lifecycle management experience

• Experienced leader with proven results in people leadership and talent development in a multicultural environment

• Proven experience as a successful and decisive leader in strategic, multifunctional environments

• Managed complex projects with ambitious milestones in high pressure circumstances

• Experience challenging senior management in relation to science, data and resources

• Successful experience working in a global environment and building strong networks

• Worked on a project that required activity/milestone achievement to ‘file’ the compound and/or prepare/launch the product

• Ideally sub-team leadership experience and worked in LCT as a core team member for sufficient time to achieve a significant milestone (Phase III implementation; NDA submission, approval and launch)

Skills/Abilities:

• Proven VACC leadership; leads change by example, with an optimistic attitude towards challenges; stays resilient/effective

• Develops people through constructive feedback and encouragement and understands what motivates other people to perform at their best

• Connects with people in ways that generate enthusiasm and commitment and delivers superior results by trusting, challenging and empowering resilient, high-impact teams

• Acts from a whole system perspective, keeping an enterprise view and understands the big picture of how the organization’s mission fits in the marketplace

• Does not get overly caught-up in short-term firefighting, but balances this with the ability to devote adequate attention to strategic initiatives. Understands and seeks strategic tradeoffs with a portfolio mindset

• Infuses the entire organization with a sense of purpose and rallies support to get things done. Is entrepreneurial and takes risks; reaches beyond boundaries, and experiments with approaches

• Willingness to take tough stands, bring up the “undiscussable” (risky issues the group avoids discussing), and openly deal with difficult relationship problems

• Pays attention to the complex interaction of many variables that are involved in solving current problems

• Builds bridges across geographical, cultural, and functional boundaries to enhance collaboration

• Provides clarity and focus on a few key priorities

• In high-tension situations, seeks common ground, remains composed and centered, and maintains focused perspective

• Challenges the organization to be curious, questions the status quo and adopt new approaches

• Acknowledges and embraces the risk involved and fosters learning from it

• Fosters a culture that leverages diversity and unique perspectives

• Clearly and concisely articulates even the most complex concepts and rallies the organization around a vision for the future

• Encourages direct and open discussions about important issues

• Ability to travel globally <30%

• Fluent written and verbal English

At Roche, more than 100,000 people across 100 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity.

Basel is the headquarters of the Roche Group and one of its most important centres of pharmaceutical research. Over 10,700 employees from over 100 countries come together at our Basel/Kaiseraugst site, which is one of Roche`s largest sites. Read more.

Besides extensive development and training opportunities, we offer flexible working options, 18 weeks of maternity leave and 10 weeks of gender independent partnership leave. Our employees also benefit from multiple services on site such as child-care facilities, medical services, restaurants and cafeterias, as well as various employee events.

We believe in the power of diversity and inclusion, and strive to identify and create opportunities that enable all people to bring their unique selves to Roche.

Roche is an Equal Opportunity Employer.